Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and follow-up

评估 COVID-19 大流行对癌症筛查和随访差异的长期影响

基本信息

  • 批准号:
    10318023
  • 负责人:
  • 金额:
    $ 67.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-15 至 2026-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT: The COVID-19 pandemic has led to dramatic reductions in cancer screening and follow-up services. During the early months of the pandemic, national organizations recommended postponing all routine cancer screening, resulting in dramatic reductions in adult primary care and specialty care visits; current rates remain far below pre-pandemic levels. Modeling suggests that these reductions will result in over 57,000 missed cancer diagnoses and 10,000 excess deaths over the next decade. However, these models are largely informed by data sources made up predominantly of insured patients and lacking race/ethnicity information. Thus, more information is needed to understand the strategies and resources need to support the recovery of health systems and communities that have been most impacted by COVID-19. The effects of the pandemic on cancer screening uptake may be particularly profound for patients served by resource-limited federally qualified health centers (FQHCs), which deliver services a large share of patients with incomes below the federal poverty level and who are Latinx. Latinx populations already have some of the lowest rates of cancer screening and follow-up care in the United States and are likely to experience the largest reductions in care and slower return to normal following COVID-19. This is, in part, because their communities have been hit particularly hard by COVID-19 (e.g. high rates of COVID-19 infections and hospitalizations and job loss) and they may fear returning for preventive care even when medical authorities have deemed it safe. Our proposed mixed-methods study will estimate the impact of the COVID-19 pandemic on rates of cancer screening and follow-up in patients served by a large, diverse FQHC (Aim 1), and estimate impacts on cancer outcomes (e.g. changes in life years gained, cancers prevented, and late-stage cancer incidence) in the FQHC population building on models developed by the CRC-SPN Cancer Intervention and Surveillance Modeling Network (Aim 2). Finally, we will gather qualitative data from clinic staff and patients to identify opportunities to improve post-pandemic cancer preventive care delivery for adults served by FQHCs (Aim 3). There is a critical need to understand the long-term impacts of COVID-19-care reductions on vulnerable populations and identify opportunities to meet the ongoing cancer prevention needs of patients served by FQHCs. We will collaborate with national stakeholders to develop FQHC-specific guidance to inform future interventions to support recovery from COVID-like care disruptions Thus, our findings will support access to care and reduction of health disparities for communities most impacted by COVID-19.
项目摘要/摘要:新冠肺炎大流行导致癌症大幅减少 筛查和后续服务。在大流行的头几个月里,国家组织 建议推迟所有常规癌症筛查,导致成人初级保健大幅减少 和专科护理就诊;目前的比率仍远低于大流行前的水平。建模表明,这些 在接下来的一年里,减少癌症诊断将导致超过57,000例癌症漏诊和10,000例额外死亡 十年。然而,这些模型在很大程度上是由主要由投保人组成的数据源提供信息的 患者和缺乏种族/民族信息。因此,需要更多信息才能理解 战略和资源需要支持卫生系统和社区的恢复 受新冠肺炎影响最大的是。大流行对癌症筛查的影响可能特别 为资源有限的联邦合格医疗中心(FQHC)提供服务的患者提供 为收入低于联邦贫困水平的拉丁裔患者提供服务的比例很大。Latinx 在美国,人们的癌症筛查和后续护理的比率已经是最低的 并可能经历最大程度的护理减少和以下较慢的恢复正常 新冠肺炎。这在一定程度上是因为他们的社区受到了新冠肺炎的特别沉重打击(例如,新浪微博)。 新冠肺炎感染、住院和失业的高比率),他们可能害怕回到医院 预防性护理,即使医疗当局认为它是安全的。我们建议的混合方法研究将 估计新冠肺炎大流行对癌症筛查率和患者随访率的影响 由大型、多样化的FQHC提供服务(目标1),并估计对癌症结局的影响(例如,生命的变化 年数增加、癌症预防和晚期癌症发病率)在FQHC人口中不断增加 由CRC-SPN癌症干预和监测建模网络(AIM 2)开发的模型。最后, 我们将从诊所工作人员和患者那里收集定性数据,以确定改善大流行后的机会 FQHC为成人提供癌症预防护理(目标3)。我们迫切需要了解 新冠肺炎护理减少对弱势群体的长期影响并确定以下机会 满足FQHC服务的患者持续的癌症预防需求。我们将与国家 利益攸关方制定针对FQHC的指导,为未来的干预措施提供信息,以支持从 因此,我们的发现将支持获得护理的机会和减少健康差距 针对受新冠肺炎影响最大的社区。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GLORIA D CORONADO其他文献

GLORIA D CORONADO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GLORIA D CORONADO', 18)}}的其他基金

Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity (PRIME)
反虚假信息和实现公平的远程医疗解决方案社区合作伙伴关系 (PRIME)
  • 批准号:
    10608871
  • 财政年份:
    2022
  • 资助金额:
    $ 67.36万
  • 项目类别:
Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity (PRIME)
反虚假信息和实现公平的远程医疗解决方案社区合作伙伴关系 (PRIME)
  • 批准号:
    10706426
  • 财政年份:
    2022
  • 资助金额:
    $ 67.36万
  • 项目类别:
Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and follow-up
评估 COVID-19 大流行对癌症筛查和随访差异的长期影响
  • 批准号:
    10449261
  • 财政年份:
    2021
  • 资助金额:
    $ 67.36万
  • 项目类别:
Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and follow-up
评估 COVID-19 大流行对癌症筛查和随访差异的长期影响
  • 批准号:
    10673630
  • 财政年份:
    2021
  • 资助金额:
    $ 67.36万
  • 项目类别:
Smarter CRC Supplement for ACCSIS Patient Navigation
用于 ACCSIS 患者导航的更智能 CRC 补充
  • 批准号:
    10782890
  • 财政年份:
    2019
  • 资助金额:
    $ 67.36万
  • 项目类别:
Screening More patients for CRC through Adapting and Refining Targeted Evidence-based Interventions in Rural settings (SMARTER CRC)
通过在农村环境中调整和完善有针对性的循证干预措施(SMARTER CRC),筛查更多的 CRC 患者
  • 批准号:
    10267750
  • 财政年份:
    2019
  • 资助金额:
    $ 67.36万
  • 项目类别:
Screening More patients for CRC through Adapting and Refining Targeted Evidence-based Interventions in Rural settings (SMARTER CRC)
通过在农村环境中调整和完善有针对性的循证干预措施(SMARTER CRC),筛查更多的 CRC 患者
  • 批准号:
    10676161
  • 财政年份:
    2019
  • 资助金额:
    $ 67.36万
  • 项目类别:
Screening More patients for CRC through Adapting and Refining Targeted Evidence-based Interventions in Rural settings (SMARTER CRC)
通过在农村环境中调整和完善有针对性的循证干预措施(SMARTER CRC),筛查更多的 CRC 患者
  • 批准号:
    10250715
  • 财政年份:
    2019
  • 资助金额:
    $ 67.36万
  • 项目类别:
Screening More patients for CRC through Adapting and Refining Targeted Evidence-based Interventions in Rural settings (SMARTER CRC)
通过在农村环境中调整和完善有针对性的循证干预措施(SMARTER CRC),筛查更多的 CRC 患者
  • 批准号:
    10470250
  • 财政年份:
    2019
  • 资助金额:
    $ 67.36万
  • 项目类别:
Prediciting and addressing colonoscopy non-adherence in community settings
预测和解决社区环境中结肠镜检查不依从性
  • 批准号:
    10394857
  • 财政年份:
    2018
  • 资助金额:
    $ 67.36万
  • 项目类别:

相似海外基金

Improving Vaccination Rates Nationwide through Partnerships between the American Cancer Society
通过美国癌症协会之间的合作提高全国范围内的疫苗接种率
  • 批准号:
    8916862
  • 财政年份:
    2014
  • 资助金额:
    $ 67.36万
  • 项目类别:
AMERICAN CANCER SOCIETY
美国癌症协会
  • 批准号:
    7690422
  • 财政年份:
    2003
  • 资助金额:
    $ 67.36万
  • 项目类别:
AMERICAN CANCER SOCIETY
美国癌症协会
  • 批准号:
    7685654
  • 财政年份:
    2003
  • 资助金额:
    $ 67.36万
  • 项目类别:
AMERICAN CANCER SOCIETY
美国癌症协会
  • 批准号:
    7402258
  • 财政年份:
    2003
  • 资助金额:
    $ 67.36万
  • 项目类别:
AMERICAN CANCER SOCIETY
美国癌症协会
  • 批准号:
    7416101
  • 财政年份:
    2003
  • 资助金额:
    $ 67.36万
  • 项目类别:
AMERICAN CANCER SOCIETY
美国癌症协会
  • 批准号:
    7402259
  • 财政年份:
    2003
  • 资助金额:
    $ 67.36万
  • 项目类别:
AMERICAN CANCER SOCIETY
美国癌症协会
  • 批准号:
    7402257
  • 财政年份:
    2003
  • 资助金额:
    $ 67.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了